Skip to main content
. 2014 Oct;7(7):376–384.

Table 6.

Bleeding Events in Patients Receiving Dabigatran

Bleeding Patients/events, N (%)
Readmission for bleeding within 1 year 19 (4.1)
Bleeding noted during admission resulting in discontinuation 11 (2.4)
≥2 g/dL decrease in hemoglobin 38 (8.3)
Transfusion ≥2 units PRBC 18 (3.9)
Unique patients experiencing any bleeding 66 (14.4)
Confirmed bleeding source: GI 23 (5)

GI indicates gastrointestinal; PRBC, packed red blood cells.